Reportable segment net sales — Net Sales
Medtronic Reportable segment net sales — Net Sales increased by 0.7% to $8.99B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $8.26B to $8.99B. Over 2 years (FY 2022 to FY 2025), Reportable segment net sales — Net Sales shows an upward trend with a 6.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market adoption and demand for the company's core medical device portfolio, while a decrease may signal competitive pressure, product obsolescence, or reduced healthcare spending.
Detailed definition
This metric represents the aggregate revenue generated from all of the company's primary business segments, excluding in...
Peer comparison
This is equivalent to 'Total Segment Revenue' or 'Aggregate Segment Net Sales' reported by other diversified medical technology peers like Abbott Laboratories or Boston Scientific.
mdt_segment_reportable_segment_net_sales_net_salesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.74B | $7.74B | $7.74B | $7.74B | $7.65B | $7.92B | $8.04B | $8.30B | $7.97B | $8.37B | $8.26B | $9.17B | $8.51B | $8.93B | $8.99B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -1.1% | +3.5% | +1.4% | +3.3% | -4.0% | +5.0% | -1.3% | +11.0% | -7.3% | +4.9% | +0.7% |
| YoY Change | — | — | — | — | -1.1% | +2.4% | — | — | +4.1% | +5.6% | +2.8% | +10.5% | +6.8% | +6.7% | +8.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's reportable segment net sales — net sales?
- Medtronic (MDT) reported reportable segment net sales — net sales of $8.99B in Q1 2026.
- How has Medtronic's reportable segment net sales — net sales changed year-over-year?
- Medtronic's reportable segment net sales — net sales increased by 8.8% year-over-year, from $8.26B to $8.99B.
- What is the long-term trend for Medtronic's reportable segment net sales — net sales?
- Over 2 years (2022 to 2025), Medtronic's reportable segment net sales — net sales has grown at a 6.1% compound annual growth rate (CAGR), from $30.96B to $34.86B.
- What does reportable segment net sales — net sales mean?
- The total combined revenue generated by all of the company's primary business units.